WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics
Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.
Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:
Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.
More Articles
Congress is Taking Action to Protect Medical Innovation – Now It’s Your Turn!
This week, bipartisan Members of the House of Representatives took action to permanently repeal the medical device tax,…
Read MoreThanks to Focused Ultrasound, Kimberly Can Walk Again
I’d always been a physically active person. Like so many others, staying active helped me keep a clear…
Read MoreMarch is National Colorectal Cancer Awareness Month
Nineteen years ago, President Clinton declared March as National Colorectal Cancer Awareness Month. Increases in colorectal cancer screening have…
Read MorePhysician Spotlight: Dr. Robert Pugach
Fate took an interesting turn when I was diagnosed with prostate cancer in late 2016. For almost three decades I…
Read More